收费全文 | 1491926篇 |
免费 | 99709篇 |
国内免费 | 2586篇 |
耳鼻咽喉 | 21190篇 |
儿科学 | 49405篇 |
妇产科学 | 43414篇 |
基础医学 | 214839篇 |
口腔科学 | 40961篇 |
临床医学 | 126508篇 |
内科学 | 291323篇 |
皮肤病学 | 30909篇 |
神经病学 | 114512篇 |
特种医学 | 60967篇 |
外国民族医学 | 465篇 |
外科学 | 231195篇 |
综合类 | 28031篇 |
现状与发展 | 1篇 |
一般理论 | 347篇 |
预防医学 | 110015篇 |
眼科学 | 33766篇 |
药学 | 112804篇 |
3篇 | |
中国医学 | 2665篇 |
肿瘤学 | 80901篇 |
2018年 | 17001篇 |
2017年 | 13855篇 |
2016年 | 14354篇 |
2015年 | 17518篇 |
2014年 | 22051篇 |
2013年 | 30233篇 |
2012年 | 46651篇 |
2011年 | 44724篇 |
2010年 | 25655篇 |
2009年 | 25690篇 |
2008年 | 40557篇 |
2007年 | 44165篇 |
2006年 | 44731篇 |
2005年 | 51325篇 |
2004年 | 50996篇 |
2003年 | 45727篇 |
2002年 | 40477篇 |
2001年 | 61703篇 |
2000年 | 61148篇 |
1999年 | 55234篇 |
1998年 | 15210篇 |
1997年 | 13449篇 |
1996年 | 13709篇 |
1995年 | 12943篇 |
1994年 | 12283篇 |
1992年 | 46330篇 |
1991年 | 45862篇 |
1990年 | 45530篇 |
1989年 | 44080篇 |
1988年 | 41078篇 |
1987年 | 40167篇 |
1986年 | 38263篇 |
1985年 | 36237篇 |
1984年 | 26790篇 |
1983年 | 23105篇 |
1982年 | 13252篇 |
1981年 | 11616篇 |
1979年 | 25646篇 |
1978年 | 17764篇 |
1977年 | 15143篇 |
1976年 | 14207篇 |
1975年 | 16118篇 |
1974年 | 19129篇 |
1973年 | 18263篇 |
1972年 | 17498篇 |
1971年 | 16366篇 |
1970年 | 15268篇 |
1969年 | 14729篇 |
1968年 | 13767篇 |
1967年 | 12226篇 |
Background
One daily dose of tacrolimus (QDT) improves adherence in kidney transplant (KT) recipients. A switch from twice-daily tacrolimus (BDT) to QDT showed similar efficacy and safety.Methods
The aim of our study was to demonstrate the long-term efficacy and safety of switching from BDT to QDT in KT recipients. Preliminary results have already been published. Forty-one patients (34 men and 7 women), mean age at KT of 43.9 ± 12.7 years, underwent a 1:1 dose switch from BDT to QDT; the mean time from KT to switch was 36.6 ± 16.1 months. In our study population, 4 patients received a living donor KT and 2 received a second allograft.Results
The mean follow-up was 86.8 ± 13 months from the switch and 126.2 ± 22.3 months from KT. Graft and patient survival rates were 90.2% and 95.1%, respectively. All patients maintained stable renal function during follow-up. During the first 3 months after the switch we observed a significant decrease in tacrolimus blood level (P = .0001). No significant differences were observed regarding tacrolimus dose before and after QDT introduction (P = not significant [NS]). Fourteen patients who stopped steroids under BDT treatment and 16 patients who stopped steroids after the switch are currently steroid-free.Conclusion
Our study showed safety and efficacy in switching from BDT to QDT. After early (<1 year) dose adjustment, tacrolimus blood levels remained stable throughout follow-up. Moreover, QDT represented a valid alternative for patients showing steroid side effects. 相似文献Robotic approaches have been steadily replacing laparoscopic approaches in metabolic and bariatric surgeries (MBS); however, their superiority has not been rigorously evaluated. The main goal of the study was to evaluate the 5-year utilization trends of robotic MBS and to compare to laparoscopic outcomes.
MethodsRetrospective analysis of 2015–2019 MBSAQIP data. Kruskal-Wallis test/Wilcoxon and Fisher’s exact/chi-square were used to compare continuous and categorical variables, respectively. Generalized linear models were used to compare surgery outcomes.
ResultsThe use of robotic MBS increased from 6.2% in 2015 to 13.5% in 2019 (N= 775,258). Robotic MBS patients had significantly higher age, BMI, and likelihood of 12 diseases compared to laparoscopic patients. After adjustment, robotic MBS patients showed higher 30-day interventions and 30-day readmissions alongside longer surgery time (26–38 min).
ConclusionRobotic MBS shows higher intervention and readmission even after controlling for cofounding variables.
Graphical Abstract 相似文献